141 related articles for article (PubMed ID: 35516706)
1. Comparison of alpha 1- antitrypsin activity and phenotype in type 1 diabetic patients to healthy individuals.
Ghoreishi AS; Mahmoodi M; Khoshdel A
J Family Med Prim Care; 2022 Apr; 11(4):1377-1381. PubMed ID: 35516706
[TBL] [Abstract][Full Text] [Related]
2. An association between Type 2 diabetes and alpha-antitrypsin deficiency.
Sandström CS; Ohlsson B; Melander O; Westin U; Mahadeva R; Janciauskiene S
Diabet Med; 2008 Nov; 25(11):1370-3. PubMed ID: 19046232
[TBL] [Abstract][Full Text] [Related]
3. Impaired activity of serum alpha-1-antitrypsin in diabetes mellitus.
Hashemi M; Naderi M; Rashidi H; Ghavami S
Diabetes Res Clin Pract; 2007 Feb; 75(2):246-8. PubMed ID: 16875754
[TBL] [Abstract][Full Text] [Related]
4. Serum protease inhibitor concentrations and total antitrypsin activity in diabetic and non-diabetic children during adolescence.
Lisowska-Myjak B; Pachecka J; Kaczyńska B; Miszkurka G; Kadziela K
Acta Diabetol; 2006 Dec; 43(4):88-92. PubMed ID: 17211556
[TBL] [Abstract][Full Text] [Related]
5. Antigenic and functional levels of alpha-1-antitrypsin in serum during normal and diabetic pregnancy.
Lisowska-Myjak B; Pachecka J
Eur J Obstet Gynecol Reprod Biol; 2003 Jan; 106(1):31-5. PubMed ID: 12475578
[TBL] [Abstract][Full Text] [Related]
6. Therapeutic Potential of Alpha-1 Antitrypsin in Type 1 and Type 2 Diabetes Mellitus.
Park SS; Rodriguez Ortega R; Agudelo CW; Perez Perez J; Perez Gandara B; Garcia-Arcos I; McCarthy C; Geraghty P
Medicina (Kaunas); 2021 Apr; 57(4):. PubMed ID: 33923873
[TBL] [Abstract][Full Text] [Related]
7. Serum trypsin inhibitory capacity in normal pregnancy and gestational diabetes mellitus.
Yaghmaei M; Hashemi M; Shikhzadeh A; Mokhtari M; Niazi A; Ghavami S
Diabetes Res Clin Pract; 2009 Jun; 84(3):201-4. PubMed ID: 19344972
[TBL] [Abstract][Full Text] [Related]
8. Alpha-1-antitrypsin phenotypes and HLA-B27 typing in uveitis patients in southeast Iran.
Ghavami S; Hashemi M; Shahriari HA; Bajestani SN; de Serres FJ; Moghaddam EM; Kazemi M; Alavian SM; Taheri M; Blanco I; Fernandez Bustillo E
Clin Biochem; 2005 May; 38(5):425-32. PubMed ID: 15820772
[TBL] [Abstract][Full Text] [Related]
9. High prevalence of alpha 1 antitrypsin phenotypes in viral hepatitis B infected patients in Iran.
Hashemi M; Alavian SM; Ghavami S; de Serres FJ; Salehi M; Doroudi T; Fard AH; Mehrabifar H; Milani B; Shahri SJ
Hepatol Res; 2005 Dec; 33(4):292-7. PubMed ID: 16260177
[TBL] [Abstract][Full Text] [Related]
10. α-1 Antitrypsin Enhances Islet Engraftment by Suppression of Instant Blood-Mediated Inflammatory Reaction.
Wang J; Sun Z; Gou W; Adams DB; Cui W; Morgan KA; Strange C; Wang H
Diabetes; 2017 Apr; 66(4):970-980. PubMed ID: 28069642
[TBL] [Abstract][Full Text] [Related]
11. Alpha1-antitrypsin ameliorates islet amyloid-induced glucose intolerance and β-cell dysfunction.
Rodríguez-Comas J; Moreno-Vedia J; Obach M; Castaño C; de Pablo S; Alcarraz-Vizán G; Díaz-Catalán D; Mestre A; Horrillo R; Costa M; Novials A; Servitja JM
Mol Metab; 2020 Jul; 37():100984. PubMed ID: 32229246
[TBL] [Abstract][Full Text] [Related]
12. α 1-antitrypsin enhances insulin secretion and prevents cytokine-mediated apoptosis in pancreatic β-cells.
Kalis M; Kumar R; Janciauskiene S; Salehi A; Cilio CM
Islets; 2010; 2(3):185-9. PubMed ID: 21099312
[TBL] [Abstract][Full Text] [Related]
13. Reduced 25(OH) Vitamin D Association with Lower Alpha-1-Antitrypsin Blood Levels in Type 2 Diabetic Patients.
Lindley VM; Bhusal K; Huning L; Levine SN; Jain SK
J Am Coll Nutr; 2021 Feb; 40(2):98-103. PubMed ID: 32275481
[No Abstract] [Full Text] [Related]
14. Therapeutic potential of alpha-1 antitrypsin in human disease.
Kim M; Cai Q; Oh Y
Ann Pediatr Endocrinol Metab; 2018 Sep; 23(3):131-135. PubMed ID: 30286568
[TBL] [Abstract][Full Text] [Related]
15. Alpha 1-antitrypsin Pi-types in 965 COPD patients.
Lieberman J; Winter B; Sastre A
Chest; 1986 Mar; 89(3):370-3. PubMed ID: 3485034
[TBL] [Abstract][Full Text] [Related]
16. Liver Phenotypes of European Adults Heterozygous or Homozygous for Pi∗Z Variant of AAT (Pi∗MZ vs Pi∗ZZ genotype) and Noncarriers.
Schneider CV; Hamesch K; Gross A; Mandorfer M; Moeller LS; Pereira V; Pons M; Kuca P; Reichert MC; Benini F; Burbaum B; Voss J; Gutberlet M; Woditsch V; Lindhauer C; Fromme M; Kümpers J; Bewersdorf L; Schaefer B; Eslam M; Bals R; Janciauskiene S; Carvão J; Neureiter D; Zhou B; Wöran K; Bantel H; Geier A; Dirrichs T; Stickel F; Teumer A; Verbeek J; Nevens F; Govaere O; Krawczyk M; Roskams T; Haybaeck J; Lurje G; Chorostowska-Wynimko J; Genesca J; Reiberger T; Lammert F; Krag A; George J; Anstee QM; Trauner M; Datz C; Gaisa NT; Denk H; Trautwein C; Aigner E; Strnad P;
Gastroenterology; 2020 Aug; 159(2):534-548.e11. PubMed ID: 32376409
[TBL] [Abstract][Full Text] [Related]
17. Phenotypes and serum level of alpha-1-antitrypsin in lung cancer.
Topic A; Ljujic M; Petrovic-Stanojevic N; Dopudja-Pantic V; Radojkovic D
J BUON; 2011; 16(4):672-6. PubMed ID: 22331720
[TBL] [Abstract][Full Text] [Related]
18. Prevalence of alpha1-antitrypsin phenotypes in patients with IgA nephropathy.
Szönyi L; Dobos M; Vásárhelyi B; Héninger E; Vas T; Nagy J; Kovács T
Clin Nephrol; 2004 Dec; 62(6):418-22. PubMed ID: 15630900
[TBL] [Abstract][Full Text] [Related]
19. Outcomes for recipients of liver transplantation for alpha-1-antitrypsin deficiency–related cirrhosis.
Carey EJ; Iyer VN; Nelson DR; Nguyen JH; Krowka MJ
Liver Transpl; 2013 Dec; 19(12):1370-6. PubMed ID: 24019185
[TBL] [Abstract][Full Text] [Related]
20. Alpha-1 antitrypsin (AAT) augmentation therapy in individuals with the PI*MZ genotype: a pro/con debate on a working hypothesis.
Barjaktarevic I; Miravitlles M
BMC Pulm Med; 2021 Mar; 21(1):99. PubMed ID: 33757485
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
